肌层浸润性膀胱癌患者在根治性膀胱切除术前的NLR、PLR和LMR与术后预后的关系(3)
[5]Sun F，Zhu J，Lu S，Zhen Z，Wang J，Huang J，Ding Z，Zeng M，Sun X.An inflammation-based cumulative prognosticscore system in patients with diffuse large B cell lymphoma inrituximab era.BMC Cancer，2018， 18(1)：5.
[6]Altan M，Haberal HB，Akdogan B，Ozen H.A criticalprognostic analysis of neutrophil-lymphocyte ratio for patientsundergoing nephroureterectomy due to upper urinary tracturothelial carcinoma.Int J Clin Oncol，2017，22(5)：964-971.
, 百拇医药 [7]Belli C，Trapani D，Viale G，D’Amico P，Duso BA，DellaVigna P，Orsi F，Curigliano G.Targeting the microenvironmentin solid tumors.Cancer Treat Rev，2018，65：22-32.
[8]龚娇，周文营，陈洪平，揭育胜.HBV感染患者外周血NLR、PLR的临床意义及其与PTA的关系.新医学，2018，49(2)：105-108.
[9]魏高輝，孟宪春，宋倩倩，符含笑，郑配国，明亮.血小板淋巴细胞比和中性粒细胞淋巴细胞比辅助筛查前列腺癌患者的作用研究.中国男科学杂志，2015，10：25-30.
[10]Deng M，Ma X，Liang X，Zhu C，Wang M.Are pretreatmentneutrophil-lymphocyte ratio and platelet-lymphocyte ratio usefulin predicting the outcomes of patients with small-cell lungcancer？ Oncotarget，2017，8(23)：37200-37207.
, 百拇医药
[11]Sun X，Liu X，Liu J，Chen S，Xu D，Li W，Zhan Y，Li Y，Chen Y，Zhou Z.Preoperative neutrophil-to-lymphocyte ratioplus platelet-to-lymphocyte ratio in predicting survival for pati-ents with stage Ⅰ-Ⅱ gastric cancer.Chin J Cancer，2016，35(1)：57.
[12]Zhu M，Feng M，He F，Han B，Ma K，Zeng X，Liu Z，Liu X，Li J，Can H，Liang Y，Jia C，Zhang L.Pretreatment neutrophil-lymphocyte and platelet-lymphocyte ratio predict clinical out-come and prognosis for cervical cancer.Clin Chim Acta、2018，483：296-302.
, 百拇医药
[13]韩颖，秦燕，何小慧，杨建良，刘鹏，张长弓，周立强，周生余，桂琳，孙燕，石远凯.炎性指标在晚期弥漫大B细胞淋巴瘤中的预后分析.中华医学杂志，2018，98(16)：1250-1255.
[14]Shi S，Chen Q，Ye L，Yin D，Li X，Dai Z，He J.Prognosticvalue of systemic inflammation score in patients with hepato-cellular carcinoma after hepatectomy.Oncotarget，2017，8(45)：79366-79375.
[15]Messager M，Neofytou K，Chaudry MA，Allum WH.Prognosticimpact of preoperative platelets to lymphocytes ratio(PLR)onsurvival for oesophageal and junctional carcinoma treated withneoadjuvant chemotherapy：a retrospective monocentric study on153 patients.Eur J Surg Oncol，2015，41(10)：1316-1323.
, http://www.100md.com
[16]Hutterer GC，Sobolev N，Ehrlich GC，Gutschi T，StojakovicT，Mannweiler S，Pummer K，Zigeuner R，Pichler M，DalpiazO.Pretreatment lymphocyte-monocyte ratio as a potential prog-nostic factor in a cohort of patients with upper tract urothelialcarcinoma.J Clin Pathol，2015，68(5)：351-355.
(收稿日期：2019-01-24)
(本文编辑：林燕薇)
DOI：10.3969/j.issn.0253-9802.2019.05.006
基金项目：国家自然科学基金(81502206)
作者单位：510630广州，中山大学附属第三医院泌尿外科, 百拇医药(文向阳 如泽 高新 周祥福 李辽源 何娅娣)
[6]Altan M，Haberal HB，Akdogan B，Ozen H.A criticalprognostic analysis of neutrophil-lymphocyte ratio for patientsundergoing nephroureterectomy due to upper urinary tracturothelial carcinoma.Int J Clin Oncol，2017，22(5)：964-971.
, 百拇医药 [7]Belli C，Trapani D，Viale G，D’Amico P，Duso BA，DellaVigna P，Orsi F，Curigliano G.Targeting the microenvironmentin solid tumors.Cancer Treat Rev，2018，65：22-32.
[8]龚娇，周文营，陈洪平，揭育胜.HBV感染患者外周血NLR、PLR的临床意义及其与PTA的关系.新医学，2018，49(2)：105-108.
[9]魏高輝，孟宪春，宋倩倩，符含笑，郑配国，明亮.血小板淋巴细胞比和中性粒细胞淋巴细胞比辅助筛查前列腺癌患者的作用研究.中国男科学杂志，2015，10：25-30.
[10]Deng M，Ma X，Liang X，Zhu C，Wang M.Are pretreatmentneutrophil-lymphocyte ratio and platelet-lymphocyte ratio usefulin predicting the outcomes of patients with small-cell lungcancer？ Oncotarget，2017，8(23)：37200-37207.
, 百拇医药
[11]Sun X，Liu X，Liu J，Chen S，Xu D，Li W，Zhan Y，Li Y，Chen Y，Zhou Z.Preoperative neutrophil-to-lymphocyte ratioplus platelet-to-lymphocyte ratio in predicting survival for pati-ents with stage Ⅰ-Ⅱ gastric cancer.Chin J Cancer，2016，35(1)：57.
[12]Zhu M，Feng M，He F，Han B，Ma K，Zeng X，Liu Z，Liu X，Li J，Can H，Liang Y，Jia C，Zhang L.Pretreatment neutrophil-lymphocyte and platelet-lymphocyte ratio predict clinical out-come and prognosis for cervical cancer.Clin Chim Acta、2018，483：296-302.
, 百拇医药
[13]韩颖，秦燕，何小慧，杨建良，刘鹏，张长弓，周立强，周生余，桂琳，孙燕，石远凯.炎性指标在晚期弥漫大B细胞淋巴瘤中的预后分析.中华医学杂志，2018，98(16)：1250-1255.
[14]Shi S，Chen Q，Ye L，Yin D，Li X，Dai Z，He J.Prognosticvalue of systemic inflammation score in patients with hepato-cellular carcinoma after hepatectomy.Oncotarget，2017，8(45)：79366-79375.
[15]Messager M，Neofytou K，Chaudry MA，Allum WH.Prognosticimpact of preoperative platelets to lymphocytes ratio(PLR)onsurvival for oesophageal and junctional carcinoma treated withneoadjuvant chemotherapy：a retrospective monocentric study on153 patients.Eur J Surg Oncol，2015，41(10)：1316-1323.
, http://www.100md.com
[16]Hutterer GC，Sobolev N，Ehrlich GC，Gutschi T，StojakovicT，Mannweiler S，Pummer K，Zigeuner R，Pichler M，DalpiazO.Pretreatment lymphocyte-monocyte ratio as a potential prog-nostic factor in a cohort of patients with upper tract urothelialcarcinoma.J Clin Pathol，2015，68(5)：351-355.
(收稿日期：2019-01-24)
(本文编辑：林燕薇)
DOI：10.3969/j.issn.0253-9802.2019.05.006
基金项目：国家自然科学基金(81502206)
作者单位：510630广州，中山大学附属第三医院泌尿外科, 百拇医药(文向阳 如泽 高新 周祥福 李辽源 何娅娣)